PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 254 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $236,023 | -34.8% | 6,113 | -10.1% | 0.00% | – |
| Q3 2022 | $362,000 | -17.2% | 6,802 | -9.2% | 0.00% | – |
| Q2 2022 | $437,000 | -22.8% | 7,491 | +1.0% | 0.00% | – |
| Q1 2022 | $566,000 | +29.8% | 7,414 | +2.2% | 0.00% | – |
| Q4 2021 | $436,000 | +25.3% | 7,253 | +16.6% | 0.00% | – |
| Q3 2021 | $348,000 | +3.0% | 6,220 | +11.6% | 0.00% | – |
| Q2 2021 | $338,000 | +39.1% | 5,571 | +60.5% | 0.00% | – |
| Q1 2021 | $243,000 | +10.0% | 3,470 | +16.9% | 0.00% | -100.0% |
| Q4 2015 | $221,000 | -76.9% | 2,968 | -71.4% | 0.00% | -83.3% |
| Q2 2014 | $955,000 | – | 10,393 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |